Overview:
A pre-IND meeting is a formal consultation meeting a sponsor can have with FDA during its drugs’ development program, to clarify some technical questions that are not fully answered by FDA guidance’s and regulations.
Pre-IND meetings with FDA are considered formal meetings and can be either Type A, Type B or Type C meeting depending on the purpose of the meeting and the phase of the drug development.
About Global Regulatory Partners Inc:
Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and South Korea GRP helps many life science companies register their products in different countries in compliance with local regulations.